Grouped according to disease progression, the patients with tMDS (finally transformed into RAEB or AML) showed higher DHX9 expression than those with sMDS (stable MDS, not transformed into AML) (p < 0.001) (Figure 1D). Here, DHX9 is linked to myelodysplastic syndrome with excess blasts.